Medelis is a full service oncology CRO. We deliver a complete array of drug development services from preclinical through ...
We can provide an entire solution for your journey through the drug development process… Or we can provide a la carte serv...
Services include:  Oncology preclinical development Quality assurance and regulatory compliance Site identification, quali...
Now delivers all of our services for European, US and Asian sponsors.
Headed by Dr. Deirdre Tessman 30 years of drug development experience and 10 years managing oncology trials in the E.C.
Our approach is driven by our deep  oncology experience and focus… It extends from our medical founders to  our CRAs and s...
Our Medical Advisory Board has a  combined 143 years of oncology  drug development experience… 422 INDs and 76 NDAs filed.
 
Mace Rothenberg, Vanderbilt-Ingram  Cancer Center John Balser, Veristat Michael Gordon, Premiere Oncology James Gourzis, B...
Our project managers have a minimum of  8 years of clinical research experience… Our CRAs have a minimum of 4 years of onc...
Our medical monitors are  board-certified oncologists.
Our team has hands-on experience  in almost every type of oncology  indication and drug type.
<ul><li>Neuroendocrine tumor </li></ul><ul><li>NSCLC </li></ul><ul><li>Oral mucositis </li></ul><ul><li>Ovarian </li></ul>...
<ul><li>DNA aptamer/intercalator </li></ul><ul><li>Engineered MoAb  </li></ul><ul><li>Fibrin sealant-biologic </li></ul><u...
We manage our resources through a  single point of contact   to build a strong relationship with your team.
Medical Safety Mgt Site Data Mgt Clinical Monitoring Sponsor Project  Manager
We have solid relationships with key  academic centers ,  thought-leaders  and  research groups .
<ul><li>Corporate Affiliations </li></ul><ul><ul><li>TGen TD2, Veristat, NFCR </li></ul></ul><ul><li>Key Opinion Leaders <...
We can use sophisticated options like EDC  and internet-based patient recruitment for  phase I and phase II trials .
European Operations France US Operations Phoenix, Arizona US Clinical Operations Nashville, Tennessee Headquarters Reno, N...
To learn more, please contact us today. US Corporate Headquarters – Phoenix, Arizona Bob Bosserman, President & CEO (602) ...
Upcoming SlideShare
Loading in …5
×

Medelis: An Introduction to our Oncology CRO Services in the U.S., Europe and Asia

3,079 views

Published on

A basic presentation we use to introduce biotech and pharmaceutical companies to the oncology contract research services Medelis provides to sponsors in the U.S., Europe and Asia.

Published in: Health & Medicine, Business
1 Comment
3 Likes
Statistics
Notes
  • Fioricet is often prescribed for tension headaches caused by contractions of the muscles in the neck and shoulder area. Buy now from http://www.fioricetsupply.com and make a deal for you.
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
3,079
On SlideShare
0
From Embeds
0
Number of Embeds
44
Actions
Shares
0
Downloads
79
Comments
1
Likes
3
Embeds 0
No embeds

No notes for slide

Medelis: An Introduction to our Oncology CRO Services in the U.S., Europe and Asia

  1. 2. Medelis is a full service oncology CRO. We deliver a complete array of drug development services from preclinical through marketing approval.
  2. 3. We can provide an entire solution for your journey through the drug development process… Or we can provide a la carte services to supplement your existing resources.
  3. 4. Services include: Oncology preclinical development Quality assurance and regulatory compliance Site identification, qualification, management, contracting & payment Medical writing Protocol development Document preparation and production Investigator identification and recruitment Medical monitoring and management Oncology patient recruitment and accrual strategies
  4. 5. Now delivers all of our services for European, US and Asian sponsors.
  5. 6. Headed by Dr. Deirdre Tessman 30 years of drug development experience and 10 years managing oncology trials in the E.C.
  6. 7. Our approach is driven by our deep oncology experience and focus… It extends from our medical founders to our CRAs and statisticians.
  7. 8. Our Medical Advisory Board has a combined 143 years of oncology drug development experience… 422 INDs and 76 NDAs filed.
  8. 10. Mace Rothenberg, Vanderbilt-Ingram Cancer Center John Balser, Veristat Michael Gordon, Premiere Oncology James Gourzis, Biopharma R&D Consultant Dan Von Hoff, TGEN
  9. 11. Our project managers have a minimum of 8 years of clinical research experience… Our CRAs have a minimum of 4 years of oncology hands-on experience.
  10. 12. Our medical monitors are board-certified oncologists.
  11. 13. Our team has hands-on experience in almost every type of oncology indication and drug type.
  12. 14. <ul><li>Neuroendocrine tumor </li></ul><ul><li>NSCLC </li></ul><ul><li>Oral mucositis </li></ul><ul><li>Ovarian </li></ul><ul><li>Pancreatic </li></ul><ul><li>Pediatrics </li></ul><ul><li>Prostate Renal </li></ul><ul><li>Sarcoma </li></ul><ul><li>Solid tumors </li></ul><ul><li>Solid tumors/lymphoma </li></ul><ul><li>Thoracic indications </li></ul><ul><li>GIST </li></ul><ul><li>Glioblastoma </li></ul><ul><li>Gliomas </li></ul><ul><li>Head and neck </li></ul><ul><li>Hepatic </li></ul><ul><li>Hepatocellular </li></ul><ul><li>ITP </li></ul><ul><li>Leukemias </li></ul><ul><li>Lymphoma </li></ul><ul><li>Malignant ascites </li></ul><ul><li>Melanoma </li></ul><ul><li>Multiple myeloma </li></ul><ul><li>Neuro indications </li></ul><ul><li>AML </li></ul><ul><li>Bone marrow transplant </li></ul><ul><li>Breast </li></ul><ul><li>Cervical </li></ul><ul><li>Cervical hyperplasia </li></ul><ul><li>CLL </li></ul><ul><li>CML </li></ul><ul><li>Colorectal </li></ul><ul><li>Endometrial </li></ul><ul><li>Gastrointestinal stroma tumor </li></ul><ul><li>Genitourinary indications </li></ul><ul><li>GI indications </li></ul>
  13. 15. <ul><li>DNA aptamer/intercalator </li></ul><ul><li>Engineered MoAb </li></ul><ul><li>Fibrin sealant-biologic </li></ul><ul><li>Growth factors </li></ul><ul><li>Genitourinary indications </li></ul><ul><li>Monoclonal antibody </li></ul><ul><li>Multifunctional polypetide agonist </li></ul><ul><li>Oral rinse </li></ul><ul><li>Tubulin inhibitor </li></ul><ul><li>Tumour-VDA </li></ul><ul><li>Tyrosine kinase HER1 inhibitor </li></ul><ul><li>Tyrosine kinase inhibitor </li></ul><ul><li>Vaccine </li></ul><ul><li>Alkylating agent </li></ul><ul><li>Alkylator </li></ul><ul><li>Anthracycline </li></ul><ul><li>Anti-angiogenesis </li></ul><ul><li>Antibody </li></ul><ul><li>Antisense </li></ul><ul><li>AntiVEGF/ angiogenesis inhibitor </li></ul><ul><li>Biologic, gene therapy </li></ul><ul><li>Camptothecin derivative </li></ul><ul><li>Chemo </li></ul><ul><li>Chemo/antibody </li></ul><ul><li>Chemo/radiation </li></ul><ul><li>Diagnostic </li></ul>
  14. 16. We manage our resources through a single point of contact to build a strong relationship with your team.
  15. 17. Medical Safety Mgt Site Data Mgt Clinical Monitoring Sponsor Project Manager
  16. 18. We have solid relationships with key academic centers , thought-leaders and research groups .
  17. 19. <ul><li>Corporate Affiliations </li></ul><ul><ul><li>TGen TD2, Veristat, NFCR </li></ul></ul><ul><li>Key Opinion Leaders </li></ul><ul><ul><li>All cancer types </li></ul></ul><ul><ul><li>Multiple disciplines </li></ul></ul><ul><li>Academic Centers </li></ul><ul><ul><li>NCI-designated Comprehensive Cancer Centers </li></ul></ul><ul><li>Professional Orgs </li></ul><ul><ul><li>ASCO, ASH, AACR, etc. </li></ul></ul><ul><li>Federal Agencies </li></ul><ul><ul><li>FDA, NIH, NCI </li></ul></ul><ul><li>Cooperative Groups </li></ul><ul><ul><li>ECOG, SWOG, RTOG, GOG, ACoSOG, etc. </li></ul></ul>
  18. 20. We can use sophisticated options like EDC and internet-based patient recruitment for phase I and phase II trials .
  19. 21. European Operations France US Operations Phoenix, Arizona US Clinical Operations Nashville, Tennessee Headquarters Reno, Nevada Data Management Boston, Massachusetts
  20. 22. To learn more, please contact us today. US Corporate Headquarters – Phoenix, Arizona Bob Bosserman, President & CEO (602) 840-1101 Medelis Europe – Port Vendres, France Deirdre Tessman, Managing Director +33 0666 622 723

×